Search clinical trials for: PR1:169-177 Peptide

Total 282 results

National Heart, Lung, and Blood Institute (NHLBI)

Completed

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Chronic Myeloid Leukemia (CML)

United States
Inge Marie Svane

Completed

Dual Vaccine Trial in Myeloproliferative Neoplasms

Polycythemia Vera | Essential Thrombocythemia

Denmark
Egymedicalpedia

Completed

Evaluation of the Effect of Self-Assembling Peptide P11-4

Dental Caries

Egypt
M.D. Anderson Cancer Center
The Vaccine Company

Terminated

PR1 Vaccination in Myelodysplastic Syndrome (MDS)

Leukemia | Myelodysplastic Syndrome

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
Laboratorios Sophia S.A de C.V.

Completed

Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan® (PRO-179/I)

Glaucoma

Mexico
Leiden University
Dutch Cancer Society; ISA Pharmaceuticals; Top Institute Pharma

Completed

Hespecta Vaccination in HPV+ Tumors or Malignant Lesions

Tumors or Premalignant Lesions

Netherlands
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Adult Acute Myeloid Leukemia in Remission | Accelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Previously Treated Myelodysplastic Syndromes | Relapsing Chronic Myelogenous Leukemia | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess...

United States
NFlection Therapeutics, Inc.

Completed

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Neurofibromatosis 1 | Cutaneous Neurofibroma

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Cervical Cancer | Head and Neck Cancer | Esophageal Cancer | Vulvar Cancer | Anal Cancer | Penile Cancer

United States
OnKure, Inc.
University of Colorado, Denver

Completed

A Study of OKI-179 in Patients With Solid Tumors

Advanced Solid Tumors

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study of PKI-179 Administered Orally to Subjects With Solid Tumors

Advanced Malignant Solid Tumors
Heart Failure Biomarker Group

Completed

A Health Economic Evaluation of Using N-Terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) in Acute Heart Failure

Heart Failure

Indonesia
OnKure, Inc.

Active, not recruiting

NAUTILUS: OKI-179 Plus Binimetinib in Patients With Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NRAS-mutated Melanoma (Phase 2)

Melanoma | NRAS Gene Mutation | RAS Mutation

United States
Amgen

Completed

A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women

Osteopenia
European Organisation for Research and Treatment...

Completed

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Cervical Cancer

Norway, Germany, United Kingdom, Sweden, Austria, France, Netherlands
National Cancer Institute (NCI)

Completed

Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery

Stage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IA Skin Melanoma | Stage IB Skin Melanoma

United States
Al-Azhar University

Recruiting

A577-nm Pro -Yellow Laser In Treatment of Striae Rubra

Striae Rubra

Egypt
Medical University of Lodz

Completed

Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis

Myocardial Infarction | Ischemic Stroke | Endocarditis | Patent Foramen Ovale | Embolic Stroke of Undetermined Source | Atrial Fibrillation and Flutter | Cardiac Tumor
Laboratorios Sophia S.A de C.V.

Completed

Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects. (PRO-167/I)

Dry Eye | Dry Eye Syndrome of Unspecified Lacrimal Gland

Mexico
The Vaccine Company

Unknown

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission

Leukemia

United States
NFlection Therapeutics, Inc.

Completed

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Neurofibromatosis 1 | Cutaneous Neurofibroma

United States
M.D. Anderson Cancer Center
The Vaccine Company

Terminated

Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)

Leukemia

United States
University of Chicago

Recruiting

Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver

Pancreas Cancer | Pancreatic Neuroendocrine Tumor

United States
Ain Shams University

Completed

Remineralization of White Spot Lesions Using Self-Assembling Peptide P11-4 in Primary Anterior Teeth A Randomized Clinical Trial

White Spot Lesions [Initial Caries] on Smooth Surface of Tooth

Egypt
Sue O'Dorisio
Advanced Accelerator Applications

Withdrawn

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents

Neuroendocrine Tumors | Pheochromocytoma | Paraganglioma

United States
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Perioperative Troponin I and NT Pro-BNP in Lung Resection

Thoracic Cancer | Complication,Postoperative | Cardiac Ischemia

Spain
Melanoma and Skin Cancer Trials Limited

Recruiting

Targeted Therapy and Avelumab in Merkel Cell Carcinoma (GoTHAM)

Metastatic Merkel Cell Carcinoma

Australia
Brii Biosciences Limited
VBI Vaccines Inc.; Vir Biotechnology, Inc.

Completed

Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic HBV Infection

Hepatitis B, Chronic

Australia, China, Korea, Republic of, New Zealand, Singapore, Thailand
Albert Chiou
NFlection Therapeutics, Inc.

Not yet recruiting

12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi

Epidermal Nevi | Nevus Sebaceus

United States
Assiut University

Unknown

BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19

COVID-19
University of Nebraska
National Cancer Institute (NCI); Amgen

Completed

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma

United States
George E. Peoples
Genentech, Inc.; Sellas Life Sciences Group

Completed

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

Breast Cancer

United States
Chulalongkorn University

Not yet recruiting

Venous Excess and Lung Ultrasound During Continuous Kidney Replacement Therapy in Critically Ill Patients (VExLUS-KRT)

Acute Kidney Failure Stage 3

Thailand
COL George Peoples, MD, FACS

Completed

Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer

Ovarian Cancer | Endometrial Cancer | Peritoneal Cancer | Fallopian Cancer

United States
Amgen

Completed

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Renal Insufficiency | Multiple Myeloma

United States
The Vaccine Company

Unknown

Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes

United States
Medical University of Vienna

Completed

Vasoactive Intestinal Peptide in COPD (VIPCOPD)

Pulmonary Hypertension | COPD
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; National Cancer Institute (NCI); Medarex

Completed

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Melanoma (Skin)

United States
AstraZeneca

Completed

Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in England

COVID-19

United Kingdom
Amgen

Completed

A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

Multiple Myeloma | Solid Tumors

United States, Canada
Amgen

Completed

An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density

Osteopenia
Sara V. Latorre
Instituto de Salud Carlos III; Institut d'Investigacions Biomèdiques August...

Active, not recruiting

Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy (CART19-BE-02)

Acute Lymphoid Leukemia

Spain
Cardiff University
Juvenile Diabetes Research Foundation; Diabetes Vaccine Development Centre

Completed

Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes (MonoPepT1De)

Type 1 Diabetes

United Kingdom
Steward St. Elizabeth's Medical Center of Boston...
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer

Cervical Cancer

United States
Laboratorios Sophia S.A de C.V.

Completed

Clinical Trial to Compare the Safety and Efficacy of Nanodrop® (PRO-176/I)

Dry Eye

Mexico
Italfarmaco S.A

Completed

Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

Vaginal Atrophy

Spain
AstraZeneca

Completed

Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines (ATTEST)

Covid-19

United Kingdom
Amgen

Completed

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Multiple Myeloma

United States, Canada
Federal Budgetary Research Institution State Research...

Completed

Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above

Covid19

Russian Federation

Search clinical trials for: PR1:169-177 Peptide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations